| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Investigative Ophthalmology & Visual Science, Vol 34, 23-30, Copyright © 1993 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
LR Pasquale, ME Dorman-Pease, GA Lutty, HA Quigley and HD Jampel
Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
PURPOSE. To determine the distribution of transforming growth factor type beta (TGF-beta) in the anterior segment of the human eye. This knowledge is important because TGF-beta may regulate various physiologic responses in the anterior segment by controlling cell proliferation and differentiation, angiogenesis, and extracellular matrix composition. METHODS. Immunohistochemical methods were used to localize the beta 1, beta 2, and beta 3 isoforms of TGF-beta in the anterior segment of the human eye. RESULTS. Eight of eight eyes (six eye bank specimens and two eyes enucleated because of choroidal melanoma) exhibited staining for at least one of the TGF-beta isoforms. TGF-beta 1 was found in superficial limbal epithelial cells (four of eight eyes) and in the stroma proximal to the ciliary processes (seven of eight eyes). TGF-beta 2 was found in superficial limbal epithelial cells (six of eight eyes), the conjunctival stroma (eight of eight eyes), in the ciliary processes (three of eight eyes), and in a diffuse distribution in the region of the radial and circular muscles of the ciliary body (eight of eight eyes). In addition, TGF-beta 2 was found in the stroma adjacent to the pigmented epithelium in the pars plana (eight of eight eyes). TGF-beta 3 was found in white blood cells in one of eight specimens; otherwise it was not found in the anterior segment. The corneal stroma, corneal endothelium, trabecular meshwork, iris, and ciliary epithelia did not exhibit immunoreactivity with the antibodies used in this study. CONCLUSION. TGF-beta 1 and TGF-beta 2 have a distinct and specific distribution in the anterior segment of the adult human eye.
This article has been cited by other articles:
|
|
 |
|
  M. E Polak, N. J Borthwick, P. Johnson, J. L Hungerford, B. Higgins, S. Di Palma, M. J Jager, and I. A Cree Presence and phenotype of dendritic cells in uveal melanoma Br J Ophthalmol, July 1, 2007; 91(7): 971 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. LaGier, S. H. Yoo, E. C. Alfonso, S. Meiners, and M. E. Fini Inhibition of Human Corneal Epithelial Production of Fibrotic Mediator TGF-{beta}2 by Basement Membrane-Like Extracellular Matrix Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1061 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priglinger, C. S. Alge, D. Kook, M. Thiel, R. Schumann, K. Eibl, A. Yu, A. S. Neubauer, A. Kampik, and U. Welge-Lussen Potential role of tissue transglutaminase in glaucoma filtering surgery. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3835 - 3845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Carrington, J. Albon, I. Anderson, C. Kamma, and M. Boulton Differential Regulation of Key Stages in Early Corneal Wound Healing by TGF-{beta} Isoforms and Their Inhibitors Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1886 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Meyer-ter-Vehn, S. Gebhardt, W. Sebald, M. Buttmann, F. Grehn, G. Schlunck, and P. Knaus p38 Inhibitors Prevent TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1500 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-S. Kim, L. Luo, S. C. Pflugfelder, and D.-Q. Li Doxycycline Inhibits TGF-{beta}1-Induced MMP-9 via Smad and MAPK Pathways in Human Corneal Epithelial Cells Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 840 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Burton, R. L. Bailey, D. Jeffries, D. C. W. Mabey, and M. J. Holland Cytokine and Fibrogenic Gene Expression in the Conjunctivas of Subjects from a Gambian Community Where Trachoma Is Endemic Infect. Immun., December 1, 2004; 72(12): 7352 - 7356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Esson, A. Neelakantan, S. A. Iyer, T. D. Blalock, L. Balasubramanian, G. R. Grotendorst, G. S. Schultz, and M. B. Sherwood Expression of Connective Tissue Growth Factor after Glaucoma Filtration Surgery in a Rabbit Model Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 485 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Mead, T. T. L. Wong, M. F. Cordeiro, I. K. Anderson, and P. T. Khaw Evaluation of Anti-TGF-{beta}2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma Surgery Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3394 - 3401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Brissette-Storkus, S. M. Reynolds, A. J. Lepisto, and R. L. Hendricks Identification of a Novel Macrophage Population in the Normal Mouse Corneal Stroma Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2264 - 2271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Wormstone, S. Tamiya, I. Anderson, and G. Duncan TGF-{beta}2-Induced Matrix Modification and Cell Transdifferentiation in the Human Lens Capsular Bag Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2301 - 2308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hayashida-Hibino, H. Watanabe, K. Nishida, M. Tsujikawa, T. Tanaka, Y. Hori, Y. Saishin, and Y. Tano The Effect of TGF-{beta}1 on Differential Gene Expression Profiles in Human Corneal Epithelium Studied by cDNA Expression Array Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1691 - 1697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dushku, M. K. John, G. S. Schultz, and T. W. Reid Pterygia Pathogenesis: Corneal Invasion by Matrix Metalloproteinase Expressing Altered Limbal Epithelial Basal Cells Arch Ophthalmol, May 1, 2001; 119(5): 695 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shafiee, J. S. Penn, H. C. Krutzsch, J. K. Inman, D. D. Roberts, and D. A. Blake Inhibition of Retinal Angiogenesis by Peptides Derived from Thrombospondin-1 Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2378 - 2388. [Abstract] [Full Text]
|
|
|
|
|
|
T. Masos, J. A. Dan, and R. Miskin Plasminogen Activator Inhibitor-1 mRNA Is Localized in the Ciliary Epithelium of the Rodent Eye Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1006 - 1011. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Cordeiro, S. S. Bhattacharya, G. S. Schultz, and P. T. Khaw TGF-{beta}1, -{beta}2, and -{beta}3 In Vitro: Biphasic Effects on Tenon’s Fibroblast Contraction, Proliferation, and Migration Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 756 - 763. [Abstract] [Full Text]
|
|
|
|
|
|
W R MEACOCK, D J SPALTON, and M R STANFORD Role of cytokines in the pathogenesis of posterior capsule opacification Br J Ophthalmol, March 1, 2000; 84(3): 332 - 336. [Full Text]
|
|
|
|
|
|
N. Dushku, S. L. S. Hatcher, D. M. Albert, and T. W. Reid p53 Expression and Relation to Human Papillomavirus Infection in Pingueculae, Pterygia, and Limbal Tumors Arch Ophthalmol, December 1, 1999; 117(12): 1593 - 1599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, J. A. Gay, and P. T. Khaw Human Anti-Transforming Growth Factor-{beta}2 Antibody: A New Glaucoma Anti-Scarring Agent Invest. Ophthalmol. Vis. Sci., September 1, 1999; 40(10): 2225 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, L.-Y. Wu, G.-S. Wu, and N. A. Rao Differential Expression of Nitric Oxide Synthase in Experimental Uveoretinitis Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 1899 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, M. B. Reichel, J. A. Gay, F. D’Esposita, R. A. Alexander, and P. T. Khaw Transforming Growth Factor-{beta}1, -{beta}2, and -{beta}3 In Vivo: Effects on Normal and Mitomycin C-Modulated Conjunctival Scarring Invest. Ophthalmol. Vis. Sci., August 1, 1999; 40(9): 1975 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M F CORDEIRO and P T KHAW The healing optic nerve in glaucoma: transforming growth factor beta and optic nerve head remodelling Br J Ophthalmol, February 1, 1999; 83(2): 132 - 133. [Full Text]
|
|
|
|
|
|
J. D O Pena, A. W Taylor, C. S Ricard, I. Vidal, and M R. Hernandez Transforming growth factor beta isoforms in human optic nerve heads Br J Ophthalmol, February 1, 1999; 83(2): 209 - 218. [Abstract] [Full Text]
|
|
|
|
|
|
K. Hirase, T. Ikeda, C. Sotozono, K. Nishida, H. Sawa, and S. Kinoshita Transforming Growth Factor {beta}2 in the Vitreous in Proliferative Diabetic Retinopathy Arch Ophthalmol, June 1, 1998; 116(6): 738 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Hales, C. G. Chamberlain, C. R. Murphy, and J. W. McAvoy Estrogen Protects Lenses against Cataract Induced by Transforming Growth Factor-{beta} (TGF{beta}) J. Exp. Med., January 20, 1997; 185(2): 273 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sanford, I Ormsby, A. Gittenberger-de Groot, H Sariola, R Friedman, G. Boivin, E. Cardell, and T Doetschman TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes Development, January 7, 1997; 124(13): 2659 - 2670. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
